CEPI (Coalition for Epidemic Preparedness Innovations)
Leonie van Tongeren is an experienced professional with a robust background in resource mobilization and stakeholder engagement within international and philanthropic organizations. As the Senior Manager of Resource Mobilisation and Investor Relations at CEPI since September 2020, Leonie manages relationships with European governments and drives initiatives to secure sustainable funding for pandemic preparedness. Prior to this role, Leonie served as Fund Manager at Civitates, overseeing grantmaking for a European democracy initiative, and held various positions at the Open Society Foundations, providing strategic support for projects across Europe. Leonie’s career also includes roles focused on human rights and international relations, alongside academic credentials such as an LL.M. in International Relations from the Institut Barcelona d’Estudis Internacionals.
This person is not in any teams
This person is not in any offices
CEPI (Coalition for Epidemic Preparedness Innovations)
2 followers
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the COVID-19 pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI’s partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX. CEPI’s 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Betacoronaviruses, and create a “library” of vaccine candidates for use against known and unknown pathogens. The plan is available at www.endpandemics.cepi.net